CAPILLARYInformation Technology

Capillary Technologies India Limited

Software Products · ISIN INE0ILV01024 · BSE 544614 · NSE EQ · FV ₹2
Last price
₹449
-0.69%today
What this company does

Capillary Technologies India Limited operates in Software Products, part of the Information Technology sector. It booked ₹257 cr of revenue in its latest quarter (Q1 FY27) and kept -3.7% of sales as profit. It is the 4th largest of 9 Software Products companies we track, by market value.

47out of 100
Equitytale Health Score
Mixed

Healthier than 47% of companies in Information Technology, on the 5 of 6 measures we could read for it. Each measure is ranked against the 81–123 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
36

At close. Not part of the score.

Profitability & returns9

How much profit it earns on the money it employs

Balance sheet44

How much it owes, and whether earnings cover the interest

Cash quality86

Whether reported profit actually arrives as cash

Valuation40

What today's price implies, against our models or its peers

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Not measurable for this company: growth & consistency. Those pillars are left out of the score rather than counted as zero.

Is this company doing well?
not investment advice
Some things to watch
Strengths
Promoters hold 51%
No promoter shares pledged
Virtually debt-free
Watch-outs
! Currently loss-making
! Thin -3.7% net margin
! Low -3.7% return on equity

What if I invest in CAPILLARY?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 5% a year, it would become
₹15.50 lakh

The slider starts at 5%, taken from a generic assumption, not this company's history. That is history, not a forecast — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹449 -0.69%
latest close · 2026-09-17
52-wk low ₹43842 sessions so far52-wk high ₹597
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/B ratio3.49High
Below bookModerateHigh
EV / EBITDA70.9High
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity-3.7%Loss
WeakFairStrong ▸15%
Return on capital-2.8%Loss
WeakFairStrong
Net margin-3.7%Loss
ThinDecentStrong
EBITDA margin4.9%Thin
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.04Comfortable
LowModerateHigh ▸1
Interest cover-6.4×Risky
RiskyOkayStrong ▸5×
Current ratio2.80Ample
Tight ◂1HealthyAmple
More figures
Market cap
₹3,568 cr
Book value
₹129
EPS
₹-1.20
latest quarter
Net debt
₹9 cr
owes more than its cash
Enterprise value
₹3,577 cr
EBITDA
₹50 cr
annualised
EBIT
₹-30 cr
annualised
Operating margin
-2.9%
Return on assets
-2.9%
Earnings yield
P/S
3.48
Sales / share
₹129.2
Tax rate
Face value
₹2
Shares
7.9 cr
Working capital
₹464 cr
Current assets
₹721 cr
Current liabilities
₹257 cr
Delivery %
57.9%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-09-17.

Worth vs price · from the exchange filings
not investment advice
Hard to value confidentlyLow confidence
Too few reliable models — the filings don't support two independent estimates of value.
Models span ₹151₹151, midpoint ₹151

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q1 FY27 (consolidated)
Revenue from Operations₹257 cr
Other Income₹6 cr
Total Income₹262 cr
Cost of Materials₹0 cr
Purchases of Stock-in-Trade₹0 cr
Employee Benefit Expense₹120 cr
Finance Costs₹1 cr
Depreciation & Amortisation₹20 cr
Other Expenses₹97 cr
Total Expenses₹238 cr
Exceptional Items₹-33 cr
Profit before Tax₹-9 cr
Tax Expense₹96.4 L
Net Profit₹-10 cr
Net margin on total income-3.6%
Where the money goes · Q1 FY27
% of total spend
Employee benefit expense₹120 cr50.2%
Finance costs₹1 cr0.5%
Depreciation & amortisation₹20 cr8.4%
Other expenses₹97 cr40.5%
Tax expense₹96.4 L0.4%
Total income ₹262 cr

The company made a net loss of ₹10 cr this quarter — income covered only 110 of every ₹100 it spent on costs and tax.

Quarterly results · consolidated (₹ cr)
MetricQ3 FY26Q4 FY26Q1 FY27
Revenue184 cr191 cr257 cr
Total income188 cr198 cr262 cr
Expenses180 cr181 cr238 cr
Profit before tax8 cr42 cr-9 cr
Tax12.8 L-88.9 L96.4 L
Net profit (owners' share)8 cr43 cr-10 cr
Net margin (owners' share, on revenue)4.3%22.7%-3.7%
EPS (₹)1.055.47-1.20
Balance sheet & cash flow · as of Mar 2026
Debt-free
Total assets
₹1,300 cr
Shareholder equity
₹1,023 cr
parent shareholders
Total debt
₹45 cr
Cash
₹36 cr
Peer comparison
Software Products · by market value
CompanyPriceMarket capP/E
Oracle Financial Services Software Limited₹11,620₹1.01 L cr17.9
Tanla Platforms Limited₹495₹6,567 cr11.5
C.E. Info Systems Limited₹890₹4,872 cr24.5
Capillary Technologies India Limitedthis company₹449₹3,568 cr
Ramco Systems Limited₹565₹2,125 cr882.6
Nucleus Software Exports Limited₹691₹1,820 cr19.1
Subex Limited₹20₹1,118 cr19.1
Quick Heal Technologies Limited₹152₹827 cr
Unicommerce Esolutions Limited₹84₹806 cr43.1
Same industry · latest reported numbers · not a recommendation.
Who owns it · 2026-06-30
No pledge
Promoter
51.5%
FII / Foreign
3.3%
DII / Domestic
19.4%
Retail / others
25.8%
Promoter stake down 0.7% over the last 4 quarters.
Smart-money activity
Bulk / block deals
SoldSWETABEN HARDIK SHAH · NSE4.19 L @ ₹525.8110 Aug 26
BoughtSWETABEN HARDIK SHAH · NSE18,833 @ ₹525.1710 Aug 26
SoldSETU SECURITIES PVT LTD · NSE4.84 L @ ₹525.1610 Aug 26
Stake changes
SoldCapillary Technologies International Pte ltd · promoter→ 44.78% · 32.92 L10 Aug 26
SoldCapillary Technologies International Pte ltd · promoter→ 44.78% · 32.92 L10 Aug 26
SoldMirae Asset Mutual Fund→ 3.47% · 4.00 L19 Jun 26
What shareholders were asked to approve
2 proposals passed only on promoter votes

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Yearly shareholder meeting · 28 Aug 2026
See the official result
1
To consider and adopt the Audited Standalone Financial Statements along with the Reports of the Board of Directors and of the Statutory Auditors thereon for the Financial Year ended March 31, 2026.
Backed by 100% of shareholders other than promotersneeded 50%
1.80 cr votes for, 5 against · 0% of mutual funds and other big investors said no
2
To receive, consider and adopt the Audited Consolidated Financial Statements along with the reports of the Statutory Auditors thereon for the Financial Year ended March 31, 2026.
Backed by 100% of shareholders other than promotersneeded 50%
1.80 cr votes for, 5 against · 0% of mutual funds and other big investors said no
3
To appoint a Director in place of Mr. Aneesh Reddy Boddu (DIN: 02214511), who retires by rotation and being eligible, offers himself for re-appointment.
Promoters had a personal stake in this
Backed by 100% of shareholders other than promotersneeded 50%
1.80 cr votes for, 87 against · 0% of mutual funds and other big investors said no

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 22 named members
owning 51.4% between them · as of 2026-06-30
Capillary Technologies International Pte Ltd48.92%
Aneesh Reddy Boddu2.18%
Neytiri Holdings0.24%
Mohan Boddu Reddy0.06%
Aditya Reddy Boddu0.03%
Pavani Pulla Reddy0.01%
Amireddy Jaipal Reddyno shares
Amireddy Rama Reddyno shares

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

Money it raised, and what it did with it

When a company raises money from investors, it has to say up front what the money is for. The rules then make it report, every three months until the money is gone, how much of each of those things it has actually paid for — so a promise made while asking for the money can be checked afterwards.

₹345 cr raised in Nov 2025 by selling shares to the public

The company has not broken this money down into purposes in its filing for Jun 2026, so there is nothing to measure it against yet. Crisil Ratings Limited watches the spending on the exchange’s behalf.

Every figure above is taken from the statement the company files with the stock exchange each quarter, for as long as money it has raised remains unspent. The only thing we work out is how much of each stated purpose has been paid for — one number divided by another from the same filing. Whether a plan that changed was a good change is not something a filing can tell you. See the filing

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.